Piperlongumine inhibits glioblastoma proliferation by inducing ferroptosis
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgae148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Jianting Qiu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Liaoning University of Traditional Chinese Medicine, Shenyang 110000, China. Hauptthemen laut MEDLINE: Ferroptosis, Dioxolanes, Glioblastoma, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objectives
This study aimed to investigate the effects of Piperlongumine on Glioblastoma multiforme.
Methods
The effects of Piperlongumine on the viability and proliferation of glioma cells LN229 and A172 were measured. Changes in mitochondrial structure were observed. Cell proliferative capacity was assessed using immunofluorescence. The levels of glutathione, malondialdehyde, 4-hydroxynonenal, and intracellular reactive oxygen species were detected. The levels of ferroptosis-related proteins were detected. A plasmid transfection was performed to overexpress the nuclear factor erythroid 2-related factor 2 gene; a subcutaneous tumor model was established in nude mice to observe the in vivo inhibitory effects of Piperlongumine on Glioblastoma multiforme and the recovery effect of Fer-1. The expression levels of ferroptosis-related proteins were detected using immunohistochemistry. Key findings Piperlongumine inhibited the viability of glioma cells, as well as their proliferation. The ferroptosis inhibitors were able to restore the inhibitory effect of Piperlongumine on glioma cell proliferation. Forced overexpression of nuclear factor erythroid 2-related factor 2 partially reversed Piperlongumine-induced ferroptosis; Piperlongumine exhibited a significant inhibitory effect on Glioblastoma multiforme cells in vivo, which could be restored by Fer-1.
Conclusions
Piperlongumine inhibits Glioblastoma multiforme proliferation by inducing ferroptosis in vitro and vivo model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liaoning University of Traditional Chinese Medicine, Shenyang 110000, China.
- Department of Neurology, The People's Hospital of Liaoning Province, Shenyang 110000, China.
- Department of Neurosurgery, Guangxi Medical University Cancer Hospital & Guangxi Cancer Institute, Nanning 530000, China.
- Department of Neurosurgery, Liaoning Cancer Hospital & Institute, Shenyang 110000, China.
- Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China.
ORCID-Profile: Haozhe Piao
Zitieren
APA
Qiu, J., Guo, F., Shi, J., Guo, T., & Piao, H. (2025). Piperlongumine inhibits glioblastoma proliferation by inducing ferroptosis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae148
Vancouver
Qiu J, Guo F, Shi J, Guo T, Piao H. Piperlongumine inhibits glioblastoma proliferation by inducing ferroptosis. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae148
BibTeX
@article{Qiu2025,
author = {Qiu, Jianting and Guo, Fangzhou and Shi, Ji and Guo, Tangjun and Piao, Haozhe},
title = {Piperlongumine inhibits glioblastoma proliferation by inducing ferroptosis},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgae148}
}
EUVIMED